Rational, Vision and Control of Immune Oncology: Checkpoint- Inhibition as new Therapy Column of Tumour Therapy

Hauschild Axel; Mohr Peter

首页> 外文期刊>Oncology research and treatment. >Rational, Vision and Control of Immune Oncology: Checkpoint- Inhibition as new Therapy Column of Tumour Therapy

【24h】

Rational, Vision and Control of Immune Oncology: Checkpoint- Inhibition as new Therapy Column of Tumour Therapy

机译：免疫肿瘤学的理性，视觉和控制：检查点抑制作为肿瘤疗法的新疗法专栏

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Oncology research and treatment.》 |2015年第s3期|共4页
作者
Hauschild Axel; Mohr Peter;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Rational, Vision and Control of Immune Oncology: Checkpoint- Inhibition as new Therapy Column of Tumour Therapy [J] . Hauschild Axel, Mohr Peter Oncology research and treatment. . 2015,第S3期

机译：免疫肿瘤学的理性，视觉和控制：检查点抑制作为肿瘤疗法的新疗法专栏
2. Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy [J] . Emily Z. Keung, Jen-Wei Tsai, Ali M. Ali, Oncoimmunology. . 2018,第2期

机译：对放射治疗的末端和躯干未分化的牙龈肉瘤免疫浸润的分析：组合Neoadjuvant免疫检查点抑制和放疗的理由
3. A randomized controlled trial comparing primary tumour resection plus systemic therapy with systemic therapy alone in metastatic breast cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017 [J] . ShienT., NakamuraK., ShibataT., Japanese journal of clinical oncology. . 2012,第10期

机译：一项随机对照试验比较了转移性乳腺癌中原发肿瘤切除加全身治疗与单纯全身治疗的比较（PRIM-BC）：日本临床肿瘤学小组研究JCOG1017
4. RADIOTHERAPY PROCEDURES QUALITY CONTROL PROGRAM:GUIDELINES ESTABLISHED BY THE SPANISH SOCIETY OFRADIOTHERAPY AND ONCOLOGY [C] . A. Palacios, J. Pardo, A. Valls, International Conference on Radiological Protection of Patients in Diagnostic and Interventional Radiology, Nuclear Medicine and Radiotherapy, Mar 26-30, 2001, In Malaga, Spain . 2001

机译：放射治疗程序执行质量控制程序： r n由西班牙放射疗法和肿瘤学学会制定的指南
5. Tumour gene therapy using adenoviral vectors expressing tumour necrosis factor alpha. [D] . Marr, Robert Anthony. 2000

机译：使用表达肿瘤坏死因子α的腺病毒载体进行肿瘤基因治疗。
6. Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101 - Breast): a randomized placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI [O] . Edith Pituskin, Mark Haykowsky, John R Mackey, 2011

机译：心脏病学肿瘤研究试验中新疗法的多学科方法的原理和设计（MANTICORE 101-乳房）：一项随机安慰剂对照试验用于确定常规心力衰竭药物治疗是否可以预防曲妥珠单抗介导的HER2 +早期乳腺癌患者的左心室重构心脏核磁共振检查
7. A Randomized Controlled Trial Comparing Primary Tumour Resection Plus Systemic Therapy With Systemic Therapy Alone in Metastatic Breast Cancer (PRIM-BC): Japan Clinical Oncology Group Study JCOG1017 [O] . T. Shien, K. Nakamura, T. Shibata, 2012

机译：随机对照试验比较原发性肿瘤切除加上单独疗法在转移乳腺癌中的全身治疗（PRIM-BC）：日本临床肿瘤组研究JCOG1017

Rational, Vision and Control of Immune Oncology: Checkpoint- Inhibition as new Therapy Column of Tumour Therapy

著录项

相似文献

相关主题

期刊订阅